Virtu Financial LLC Sells 10,377 Shares of Cardinal Health, Inc. (NYSE:CAH)

Virtu Financial LLC trimmed its holdings in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 50.4% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 10,195 shares of the company's stock after selling 10,377 shares during the period. Virtu Financial LLC's holdings in Cardinal Health were worth $1,127,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of CAH. Paragon Capital Management Inc. grew its position in Cardinal Health by 0.7% in the 2nd quarter. Paragon Capital Management Inc. now owns 14,758 shares of the company's stock worth $1,451,000 after purchasing an additional 99 shares during the period. Midland Wealth Advisors LLC grew its holdings in shares of Cardinal Health by 4.2% in the second quarter. Midland Wealth Advisors LLC now owns 2,488 shares of the company's stock worth $245,000 after acquiring an additional 100 shares during the period. Aptus Capital Advisors LLC increased its position in Cardinal Health by 5.1% during the second quarter. Aptus Capital Advisors LLC now owns 2,071 shares of the company's stock valued at $204,000 after acquiring an additional 100 shares during the last quarter. Oregon Public Employees Retirement Fund lifted its holdings in Cardinal Health by 0.5% in the second quarter. Oregon Public Employees Retirement Fund now owns 20,891 shares of the company's stock valued at $2,054,000 after acquiring an additional 100 shares during the period. Finally, Huntington National Bank boosted its position in Cardinal Health by 0.9% in the third quarter. Huntington National Bank now owns 10,792 shares of the company's stock worth $1,193,000 after purchasing an additional 100 shares during the last quarter. Institutional investors own 87.17% of the company's stock.

Cardinal Health Stock Up 0.5 %

CAH stock traded up $0.64 during midday trading on Friday, hitting $118.10. The company's stock had a trading volume of 1,413,636 shares, compared to its average volume of 2,100,808. Cardinal Health, Inc. has a 12 month low of $93.17 and a 12 month high of $126.23. The company has a 50 day moving average of $117.12 and a two-hundred day moving average of $108.35. The firm has a market capitalization of $28.58 billion, a price-to-earnings ratio of 22.98, a price-to-earnings-growth ratio of 1.47 and a beta of 0.61.

Cardinal Health (NYSE:CAH - Get Free Report) last released its earnings results on Friday, November 1st. The company reported $1.88 EPS for the quarter, topping the consensus estimate of $1.62 by $0.26. The firm had revenue of $52.28 billion for the quarter, compared to the consensus estimate of $50.90 billion. Cardinal Health had a net margin of 0.56% and a negative return on equity of 56.56%. The company's quarterly revenue was down 4.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.73 earnings per share. On average, analysts anticipate that Cardinal Health, Inc. will post 7.82 earnings per share for the current fiscal year.

Cardinal Health Cuts Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd will be given a dividend of $0.5056 per share. The ex-dividend date is Thursday, January 2nd. This represents a $2.02 dividend on an annualized basis and a dividend yield of 1.71%. Cardinal Health's payout ratio is 39.30%.

Analyst Upgrades and Downgrades

CAH has been the subject of several research reports. Barclays upped their price target on shares of Cardinal Health from $117.00 to $133.00 and gave the company an "overweight" rating in a research report on Monday, November 4th. JPMorgan Chase & Co. upped their target price on shares of Cardinal Health from $111.00 to $123.00 and gave the company a "neutral" rating in a report on Wednesday, August 21st. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Cardinal Health from $119.00 to $124.00 and gave the stock a "hold" rating in a research note on Monday, November 4th. StockNews.com lowered Cardinal Health from a "strong-buy" rating to a "buy" rating in a research note on Sunday, November 3rd. Finally, Wells Fargo & Company upgraded Cardinal Health from an "underweight" rating to an "equal weight" rating and lifted their target price for the company from $101.00 to $127.00 in a research report on Friday. Five equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company's stock. According to data from MarketBeat.com, Cardinal Health has a consensus rating of "Moderate Buy" and an average target price of $126.75.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.